Conocarpus lancifolius
Conocarpus lancifolius · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Conocarpus lancifolius is a versatile plant species that holds significant pharmacological potential due to its diverse chemical profile. The fruit of this plant is a rich source of bioactive compounds, including anthraquinones, cardiac glycosides, flavonoids, and saponins. Scientific investigations into its methanolic extracts have revealed promising antidiabetic activities that may assist in managing blood glucose levels. Furthermore, these extracts have demonstrated efficacy in addressing conditions such as cognitive disorders and combating fungal pathogens like Aspergillus fumigatus. Consequently, the various preparations of Conocarpus lancifolius fruit represent a valuable subject for modern therapeutic research.
- Synonyms
- Conocarpus Niloticus
- Common names
- Not available
- Family
- Combretaceae
- Distribution
- Not available
- Plant Parts
- Fruit
Classification
Common Names
Conocarpus lancifolius is a versatile plant known by many different names across the globe. In English-speaking regions, it is frequently referred to as the Lanceleaf Buttonwood. It also holds the common name Mangue-pom-pom in various tropical locales. Depending on the language spoken, you may encounter it as Конокарпус ланцетолистный in Russian or دمس سناني in Arabic. Finally, many people simply identify this species by its common name, Damas.
Sources: Catalogue of Life (COL)
Synonyms
Conocarpus lancifolius is a resilient species frequently encountered in coastal and tropical landscapes. While often identified by this specific name, it is also widely recognized by its synonym, Conocarpus niloticus. This nomenclature overlap can sometimes lead to confusion among botanists and gardeners alike. Understanding these taxonomic connections is essential for accurate plant identification and documentation. Consequently, recognizing both names ensures clarity when studying the ecological role of this versatile shrub.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Conocarpus lancifolius belongs to the vast kingdom Plantae, representing a significant part of the natural world. Within this kingdom, the species is classified under the class Equisetopsida. It further descends through the order Myrtales, showcasing its evolutionary connections. The plant is a distinguished member of the family Combretaceae, which defines its unique botanical characteristics. Finally, it is identified by its specific genus, Conocarpus, marking its distinct place in biological taxonomy.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Combretaceae |
| Genus | Conocarpus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Conocarpus lancifolius exhibits a widespread distribution that spans across diverse geographical regions. In Africa, this species is found throughout Northeast Tropical Africa, specifically within the territories of Eritrea and Somalia. Its presence extends further into the Asian-Temperate zone, where it thrives within the Arabian Peninsula. Notably, the plant has established a significant foothold in the country of Yemen. This broad range highlights the plant's ability to adapt to various environments across these distinct continents.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Conocarpus lancifolius grows in a sturdy tree form that is entirely self-supporting. This resilient species can reach a maximum height of 15 meters as it matures. Its robust structure makes it a prominent feature in many landscapes.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Conocarpus lancifolius is a heat-tolerant medicinal plant native to regions such as Riyadh, Saudi Arabia. Recent pharmacological studies have highlighted the plant's significant therapeutic value, particularly its prominent antidiabetic potential. Researchers have successfully isolated several bioactive compounds from its fruits, including a new trimethoxyellagic acid derivative. Notably, these constituents demonstrate strong dual activation of PPARα and PPARγ, which are key targets in metabolic regulation. This discovery underscores the importance of exploring C. lancifolius as a natural source for managing diabetes and other inflammatory conditions.
Compounds
Conditions
Conocarpus lancifolius demonstrates significant medicinal value through its ability to treat various ailments. The plant possesses documented anti-leishmanial and antiprotozoal properties that target specific parasitic threats. It also functions as an effective antibacterial and antifungal agent against several resistant microbial strains. Furthermore, the genus has proven its utility in treating antidiabetic conditions. These diverse pharmacological attributes highlight the broad therapeutic potential of the species.
Preparations
Conocarpus lancifolius is prepared as various extracts to facilitate the study of its medicinal properties. Researchers have specifically utilized the fruit extract of the plant to demonstrate cytotoxicity against the MRC-5 cancer cell line and to isolate new ellagic acid derivatives. Furthermore, the plant is prepared as a methanol extract, which serves as a basis for identifying secondary metabolites. This methanolic extract is used to isolate novel compounds like lancifoliate for evaluating antifungal and antiproliferative potential. Finally, the biological activities of the plant are assessed through the study of both these extracts and its pure constituents.
Parts used
Conocarpus lancifolius is a heat-tolerant medicinal plant native to regions such as Riyadh, Saudi Arabia. Scientific investigations have identified the fruit of this species as a rich source of bioactive compounds, including a new trimethoxyellagic acid derivative. Extracts derived from these fruits have demonstrated significant cytotoxic effects against the MRC-5 cancer cell line. Furthermore, the fruit contains constituents that exhibit promising antiprotozoal, antibacterial, and antioxidant activities. These findings highlight the therapeutic potential of the fruit in managing inflammatory and metabolic conditions.